FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels
The EMBO Journal · 03.07.2023 · 42 (13)
DOI: 10.15252/embj.2022112799 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, online erschienen am 27.04.2023. Verfasst von Hannah Elcocks und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Mitophagy, Ubiquitin. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Parkinson's UK, Medical Research Council, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Selective autophagy of mitochondria, mitophagy, is linked to mitochondrial quality control and as such is critical to a healthy organism. We have used a CRISPR/Cas9 approach to screen human E3 ubiquitin ligases for influence on mitophagy under both basal cell culture conditions and upon acute mitochondrial depolarization. We identify two cullin‐RING ligase substrate receptors, VHL and FBXL4, as the most profound negative regulators of basal mitophagy. We show that these converge, albeit via different mechanisms, on control of the mitophagy adaptors BNIP3 and BNIP3L/NIX. FBXL4 restricts NIX and BNIP3 levels via direct interaction and protein destabilization, while VHL acts through suppression of HIF1α‐mediated transcription of BNIP3 and NIX. Depletion of NIX but not BNIP3 is sufficient to restore mitophagy levels. Our study contributes to an understanding of the aetiology of early‐onset mitochondrial encephalomyopathy that is supported by analysis of a disease‐associated mutation. We further show that the compound MLN4924, which globally interferes with cullin‐RING ligase activity, is a strong inducer of mitophagy, thus providing a research tool in this context and a candidate therapeutic agent for conditions linked to mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
- Institute of Biochemistry II, Goethe University, Medical Faculty, University Hospital, Frankfurt am Main, Germany.
- Frankfurt Cancer Institute, Frankfurt am Main, Germany.
- Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
ORCID-Profile: Hannah Elcocks, Ailbhe J Brazel, Katy R McCarron, Manuel Kaulich, Koraljka Husnjak, Heather Mortiboys, Michael J Clague, Sylvie Urbé
Förderung
- Parkinson's UK
- Medical Research Council
- Deutsche Forschungsgemeinschaft
- EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska‐Curie Actions
- Royal Society
- UKRI | Medical Research Council
Zitieren
APA
Elcocks, H., Brazel, A. J., McCarron, K. R., Kaulich, M., Husnjak, K., Mortiboys, H., Clague, M. J., & Urbé, S. (2023). FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels. The EMBO Journal, 42(13). https://doi.org/10.15252/embj.2022112799
Vancouver
Elcocks H, Brazel AJ, McCarron KR, Kaulich M, Husnjak K, Mortiboys H, et al. FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels. The EMBO Journal. 2023;42(13). doi:10.15252/embj.2022112799
BibTeX
@article{Elcocks2023,
author = {Elcocks, Hannah and Brazel, Ailbhe J and McCarron, Katy R and Kaulich, Manuel and Husnjak, Koraljka and Mortiboys, Heather and Clague, Michael J and Urbé, Sylvie},
title = {FBXL4 ubiquitin ligase deficiency promotes mitophagy by elevating NIX levels},
journal = {The EMBO Journal},
year = {2023},
volume = {42},
number = {13},
doi = {10.15252/embj.2022112799}
}
EUVIMED